Who Owns NEUP?

Neuphoria Therapeutics Inc. — Institutional Ownership & 13F Holdings

$5.25

+0.06 (+1.14%)

Market Cap

$8.5M

Shares Outstanding

5,390,895

Institutional Holders

7

Total Inst. Value

$935K

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1AdvisorShares Investments LLC$397K69,659
2Lynx1 Capital Management LP$264K45,806
3Prosperity Wealth Management, Inc.$157K27,200
4Merck & Co., Inc.$58K10,027
5Cyndeo Wealth Partners, LLC$58K10,000
6RHUMBLINE ADVISERS$2K415
7MORGAN STANLEY$07

Biggest Buyers & Sellers This Quarter

Top Buyers

FundShares AddedValue

Top Sellers

FundShares RemovedValue
RHUMBLINE ADVISERS-691$2K

Related Stocks

Frequently Asked Questions

How many institutional investors hold NEUP?

As of Q1 2025, 7 institutional investors report holding NEUP (Neuphoria Therapeutics Inc.) in their 13F filings.

Which hedge fund owns the most NEUP?

The largest institutional holder of NEUP is AdvisorShares Investments LLC with $397K in shares.

Are institutions buying or selling NEUP?

This quarter, 3 institutions opened new positions in NEUP and 4 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.